[HTML][HTML] Control of human toxoplasmosis

NC Smith, C Goulart, JA Hayward, A Kupz… - International journal for …, 2021 - Elsevier
Toxoplasmosis is caused by Toxoplasma gondii, an apicomplexan parasite that is able to
infect any nucleated cell in any warm-blooded animal. Toxoplasma gondii infects around 2 …

[HTML][HTML] Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis

Y Zhang, BS Lai, M Juhas, Y Zhang - Microbiological research, 2019 - Elsevier
T. gondii is a major opportunistic pathogen chronically infecting nearly one third of the
world's population. Due to the high infection and mortality rates in immunocompromised …

Toxoplasma gondii vaccine candidates: a concise review

AJ Mamaghani, A Fathollahi, Z Arab-Mazar… - Irish Journal of Medical …, 2023 - Springer
Toxoplasma gondii is an obligate intracellular parasite that causes toxoplasmosis. It has
been shown that the severity of symptoms depends on the functioning of the host immune …

[PDF][PDF] Rhoptry antigens as Toxoplasma gondii vaccine target

M Foroutan, F Ghaffarifar, Z Sharifi… - Clinical and …, 2019 - synapse.koreamed.org
Toxoplasmosis is a cosmopolitan zoonotic infection, caused by a unicellular protozoan
parasite known as Toxoplasma gondii that belongs to the phylum Apicomplexa. It is …

[PDF][PDF] Epidemiology of severe fever and thrombocytopenia syndrome virus infection and the need for therapeutics for the prevention

M Foroutan, F Ghaffarifar, NJC Robles… - Clinical and …, 2018 - synapse.koreamed.org
Toxoplasma gondii belongs to the Apicomplexa phylum that caused a widespread zoonotic
infection in wide range of intermediate hosts. Over one-third of the world's population are …

Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against …

M Roozbehani, R Falak, M Mohammadi, A Hemphill… - Vaccine, 2018 - Elsevier
No effective human vaccine against Toxoplasma gondii (T. gondii) has yet been developed;
however, a protective vaccine using immunogenic peptides in a safe delivery vehicle system …

Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii

C Brito, C Lourenço, J Magalhães, S Reis, M Borges - Vaccines, 2023 - mdpi.com
Nanoparticles include particles ranging in size from nanometers to micrometers, whose
physicochemical characteristics are optimized to make them appropriate delivery vehicles …

Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications

JP Assolini, VM Concato, MD Gonçalves… - Parasitology …, 2017 - Springer
Toxoplasmosis is an infectious disease caused by the intracellular parasite Toxoplasma
gondii that affects about one third of the world's population. The diagnosis of this disease is …

[HTML][HTML] Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine

M Foroutan, F Ghaffarifar - Clinical and experimental vaccine …, 2018 - synapse.koreamed.org
Toxoplasma gondii belongs to the Apicomplexa phylum that caused a widespread zoonotic
infection in wide range of intermediate hosts. Over one-third of the world's population are …

Nano dimensions/adjuvants in COVID-19 vaccines

E Alphandéry - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
A favorable outcome of the COVID-19 crisis might be achieved with massive vaccination.
The proposed vaccines contain several different vaccine active principles (VAP), such as …